SEC Form 4 · accession 0001225208-19-004743
Cigna Group · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew G Manders
Officer — President, Strategy & Solution
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 9:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739940
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par ValueF1 | Mar 1, 2019 | A | 6,999 | $0.00 | A | 50,092 | D | |
| Common Stock, $.01 Par ValueF2 | Mar 1, 2019 | F | 2,241 | $177.85 | D | 47,851 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2016-2018 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
- F2Represents shares withheld to satisfy tax obligations upon vesting.